Drug resistance testing in treatment-naive HIV patients is cost-effective
Testing for drug resistance in HIV-infected patients at the time of HIV diagnosis is cost-effective and may increase patients' life expectancy, according to an article in the Nov. 1 issue of Clinical Infectious Diseases, now available online. Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing...